(Q39375935)

11 September 2017

title

Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis (English)

1 reference

11 September 2017

5

Peter J M Rottier

1 reference

11 September 2017

author name string

Gayathri T Selvarajah

1

1 reference

11 September 2017

Monique H Verheije

2

1 reference

11 September 2017

Marja Kik

3

1 reference

11 September 2017

Adri Slob

4

1 reference

11 September 2017

Jan A Mol

6

1 reference

11 September 2017

Jolle Kirpensteijn

7

1 reference

11 September 2017

publication date

19 March 2012

1 reference

11 September 2017

published in

The Veterinary Journal

1 reference

11 September 2017

volume

193

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

412-419

1 reference

Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Establishment and characterization of the growth and pulmonary metastasis of a highly lung metastasizing cell line from canine osteosarcoma in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Development and evaluation of canine reference genes for accurate quantification of gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Expression of EGFR, HER-2/neu and KIT in germ cell tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Expression of HER2/erbB-2 correlates with survival in osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Prognostic significance of a new histologic grading system for canine osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Functional receptors for epidermal growth factor on human osteosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

C-erbB-2 expression and prognostic significance in osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.02.009

10.1016/J.TVJL.2012.02.009

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference